Bio Elpida, your CMO for Stem Cell Therapy and Regenerative Medicine
From Research to Optimisation and GMP Manufacturing

The strong experience of Bio Elpida in cell culture enables the company:
  • To develop and adapt R&D manufacturing processes to pharmaceutical constraints
  • To perform subcontracting manufacturing of regenerative medicine products based on stem cells

The company is currently involved in 2 such projects for third party companies.

An innovative approach using the pluripotency of primary cells

The goal of regenerative medicine is to repair damaged human tissues. This therapeutic approach relies on the capacities of primary cells to divide and differentiate into some cell type (pluripotency).

Practically, primary cells are isolated, purified and cultured in vitro while maintaining their pluripotency. There are then injected to a patient in order to directly regenerate the wounded organ. In some cases, an intermediate step is required: an in vitro pre-differentiation step.

Regenerative medicine could be used to cure several diseases: some cancers, diabetes, neurodegenerative diseases, side effects of radiotherapy…

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.

Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •